Beta Bionics, Inc. Common Stock (BBNX)
Smart-money score is below the middle.
BBNX scores higher than 58% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, Beta Bionics, Inc. Common Stock (BBNX) scores 45 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.72× 30-day average
- 52-week range
- 8.80 – 32.71
- Market cap
- $984.82M
- Earnings date
- 27 Oct 2026
- Volume
- 955,105
- Avg. volume (30d)
- 1,317,501
- Open
- 17.47
- Previous close
- 17.43
- Day's range (regular session)
- 17.12 – 17.88
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 0.98
- P/E (TTM)
- —
- EPS (TTM)
- -1.65
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for BBNX
- 12 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for BBNX. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about BBNX right now
Beta Bionics, Inc. Common Stock (BBNX) currently scores 45/100 on the Market Census six-factor composite, at the Average score level. BBNX is +1.15% on the day and -6.75% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in BBNX's data roughly balance out right now. BBNX's strongest factor is strength vs the market at 62/100 — a fairly good read on how BBNX has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is insider trades at 10/100 — a well below average read on insider buying and selling. Insider filings for BBNX lean toward selling; on a thinly filed name a few filings can set this reading.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See BBNX in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent BBNX news
Latest headlines that name Beta Bionics, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application DeadlineGlobeNewswire Inc.
- Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLCGlobeNewswire Inc.
- Deadline Alert: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitGlobeNewswire Inc.
- Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of an Upcoming Lead Plaintiff Deadline on November 3, 2026GlobeNewswire Inc.
- רוזן, משרד מוביל בפריסה ארצית המייצג משקיעים, מעודד את משקיעי חברת Beta Bionics, Inc לשכור ייעוץ משפטי לקראת מועד אחרון חשוב במסגרת תביעה ייצוגית בניירות ערך – BBNXGlobeNewswire Inc.
We hide 1 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to BBNX’s 45, all within 1 point.
Sorted by closeness to BBNX’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.